The anticoagulant reversal drugs market is likely to reach a valuation of US$ 1,137.35 Million in 2022. Furthermore, across the 2022-2032 period of assessment, growth is expected to accelerate at a whopping 15.0% CAGR, reaching US$ 4,601.22 Million. Bleeding disorders can happen as a result of some medications, such as blood thinners, which includes warfarin, heparin, and aspirin. The high risk of bleeding varies with the anticoagulant agent used. According to the National Center for Biotechnology Information (NCBI) data, the occurrence of bleeding for patients taking warfarin has been projected at 15-20% each year.
Life-threatening bleeding because of warfarin has been projected at a rate of 1-3% per year. Thus, increase in demand for anticoagulant therapies is further creating potential opportunities for reversal agents for anticoagulants. Increasing demand for anticoagulant reversal drugs in case of uncontrolled bleeding is expected to drive the market growth during the forecast period.
Download Sample Copy of This Report –
According to the World Health Organization (WHO), people over the age of 65 are the fastest demographic segment in the world. Between 2000 and 2050, the proportion of the world’s population over the age of 60 is expected to double, increasing from about 11% to 22%. As per the reports of CDC, approximately 2% of people below 65 years of age have atrial fibrillation, while 9% of people who are above 65 years of age have the disease. It is also estimated that almost 12.1 million people will develop atrial fibrillation by 2030. As a result, the growing elderly population is driving the global anticoagulant reversal drugs market growth during the forecast period.
Key Takeaways from the Market Study
Prominent players in the Anticoagulant Reversal Drugs Industry are taking advantage of the rapidly increasing demand for the Anticoagulant Reversal Drugs in various applications. To further their outreach, players are relying on collaborations, partnerships and acquisitions with existing small, medium and large-scale players. Some prominent market developments are as follows:
Get Customization on this Report for Specific Research Solutions –
Prominent Service Players
Key Segments Covered in the Anticoagulant Reversal Drugs Industry Survey
Get Full Access of Complete Report –
Global Anticoagulant Reversal Drugs Market Analysis and Forecast by Region
More Insights Available
Fact.MR, in its new offering, presents an unbiased analysis of the global Anticoagulant Reversal Drugs market, presenting historical analysis from 2017 to 2022 and forecast statistics for the period of 2023-2033.
The study reveals essential insights on the basis of product (prothrombin complex concentrates, vitamin k, protamine, tranexamic acid, idarucizumab, andexxa, and others), by distribution channel (hospital pharmacies, retail pharmacies, and others), across five major regions (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa).
Check out more related studies published by Fact.MR Research:
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories. We are committed to deliver insights that help businesses gain deeper understanding of their target markets. We understand that making sense of the vast labyrinth of data can be overwhelming for businesses. That’s why focus on offering insights that can actually make a difference to bottom-lines.
Specialties: Competition Tracking, Customized Research, Syndicated Research, Investment Research, Social Media Research, Business Intelligence, Industry Analysis, Thought Leadership.